Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Color-coded Markers May Help Doctors… >
Color-coded Markers May Help Doctors Diagnose Neural Diseases Through the Eyes

Published: August 15, 2012.
By University of California - San Diego
http://www.ucsd.edu

Sticky plaques of proteins called amyloids mark several different, though related degenerative brain diseases including Alzheimer's, Parkinson's and Creutzfeld-Jacobs. The symptoms of these disorders overlap and methods to diagnose and monitor them are not very advanced.

To solve this problem, scientists at the University of California, San Diego, have devised several new fluorescent probes that change color depending on what type of amyloid they encounter. Because amyloids accumulate in the eye as well as the brain, their discovery offers hope that one day neurodegenerative diseases could be differentially diagnosed with simple eye drops or ointment and an eye exam.

"The key trick here is that the small differences in the proteins that make up different forms of amyloid interact differently with our fluorescent probes to result in measurably different colors of the emitted light," said Jerry Yang who, along with Emmanuel Theodorakis, led the project. Both are professors of chemistry and biochemistry at UC San Diego. Christina Sigurdson from the Department of Pathology at UC San Diego's School of Medicine was a key collaborator in this work.

The colors vary depending on the physical properties of pockets in the different amyloid proteins. The team demonstrated that one of their probes glows yellow when marking amyloid deposits associated with prion disease, and green when it binds to amyloids associated with Alzheimer's disease in tissue samples, for example. Their findings are published online this week by the Journal of the American Chemical Society.

Among the few available diagnostics for Alzheimer's disease are radioactive molecules that target amyloid, which can be detected in the brain using positron emission tomography or PET scans. But that test only says whether amyloid has formed in the brain without distinguishing between the various types.

"We think that our approach represents a significant step towards developing diagnostics to distinguish between different, but closely related diseases where symptoms and pathological characteristics show may similarities," Yang said. "Such capability might prove to be very important for deciding on effective treatment strategies for specific diseases."

Now that they have learned how physical properties of amyloid control the colors of their markers, they are expanding their catalog to create probes for discriminating between other forms of amyloid.

The technology has been licensed for commercial development of diagnostic tests for human neural disease.






Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Proteins 
7/28/14 
★★ 

New Protein Structure Could Help Treat Alzheimer's, Related Diseases
By University of Washington
Amyloid 
9/7/10 
Harmful Amyloid Interferes with Trash Pickup for Cells in Alzheimer's Disease
By University of California - San Diego
Chemists at the University of California, San Diego, have identified how a protein that accumulates in the brains of people with Alzheimer's disease interferes with the ability of cells …
Brain 
7/9/11 
Advances in Research into Alzheimer's Disease
By BioMed Central
Advances in research into Alzheimer's disease: transporter proteins at the blood CSF barrier and vitamin D may help prevent amyloid β build up in the brain …
Murray 
3/27/12 
Role of Amyloid Beta as Sensors And Protectors in Alzheimer's And Other Diseases Explored
By IOS Press
Alzheimer's disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to …
Amyloid 
9/26/11 
Award-winning Research Points Toward Alzheimer’s Vaccine
By Georgia Health Sciences University
An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research by a Georgia Health Sciences University …
Blood 
2/4/13 
★★★ 
Damaged Blood Vessels Loaded with Amyloid Worsen Cognitive Impairment in Alzheimer's Disease
By Weill Cornell Medical College
NEW YORK (February 4, 2013) -- A team of researchers at Weill Cornell Medical College has discovered that amyloid peptides are harmful to the blood vessels that supply the …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition